Robert Lemos

1.9k citations

20 papers · 1.4k indexed · h-index 15

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Oncology top 10%
- Colorectal Cancer Treatments and Studies

Papers in ⓘ

Cancer Research 8
- Cancer, Hypoxia, and Metabolism 8
Oncology 6
- Cancer-related Molecular Pathways 3
- Pancreatic and Hepatic Oncology Research 2

Co-authors: Garth Powis (19 shared papers)Mei Yee Koh (5 shared papers)Xiuping Liu (3 shared papers)Gordon B. Mills (2 shared papers)Nathan T. Ihle (6 shared papers)D. Lynn Kirkpatrick (3 shared papers)Peter Wipf (2 shared papers)Clint Mitchell (1 shared paper)
Journals: Cancer Research (12 papers)Molecular Cancer Therapeutics (4 papers)Clinical Cancer Research (1 paper)Nano Research (1 paper)Hepatology (1 paper)
Partner nations: United States South Korea Australia

In The Last Decade

Robert Lemos

18 papers receiving 1.4k citations

Peers

Countries citing papers authored by Robert Lemos

Since Specialization

Citations

This map shows the geographic impact of Robert Lemos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lemos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lemos more than expected).

Fields of papers citing papers by Robert Lemos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Lemos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lemos. The network helps show where Robert Lemos may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Lemos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Lemos Line = papers co-authored together Robert Lemos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Hypoxia-Associated Factor Switches Cells from HIF-1α- to HIF-2α-Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion Cancer Research ·Mei Yee Koh, Robert Lemos, Xiuping Liu, Garth Powis	2011	276
2	Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents Clinical Cancer Research ·Muling Mao, Feng Tian, John M. Mariadason, Chun C. Tsao, Robert Lemos, Farshid Dayyani, Y.N. Vashisht Gopal, Zhi-Qin Jiang, Ignacio I. Wistuba, Xi Tang, William G. Bornman, Gideon Bollag, Gordon B. Mills, Garth Powis, Jayesh Desai, Gary E. Gallick, Michael A. Davies, Scott Kopetz	2012	235
3	Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance Cancer Research ·Nathan T. Ihle, Robert Lemos, Peter Wipf, Adly Yacoub, Clint Mitchell, Doris R. Siwak, Gordon B. Mills, Paul Dent, D. Lynn Kirkpatrick, Garth Powis	2008	225
4	HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer Gut ·Hae Ryung Chang, Seungyoon Nam, Myeong‐Cherl Kook, Kyung-Tae Kim, Xiuping Liu, Hui Yao, Hae Rim Jung, Robert Lemos, Hye Hyun Seo, Hee Seo Park, Youme Gim, Dongwan Hong, Iksoo Huh, Young‐Woo Kim, Dongfeng Tan, Chang‐Gong Liu, Garth Powis, Taesung Park, Han Liang, Yon Hui Kim	2014	95
5	Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer Molecular Cancer Therapeutics ·David A. Schwartz, James A. Bankson, Robert Lemos, Stephen Y. Lai, Arun K. Thittai, Yi He, Galen Hostetter, Michael J. Demeure, Daniel D. Von Hoff, Garth Powis	2010	83
6	In vivo therapeutic silencing of hypoxia-inducible factor 1 alpha (HIF-1α) using single-walled carbon nanotubes noncovalently coated with siRNA Nano Research ·Geoffrey Bartholomeusz, Paul Cherukuri, John Kingston, Laurent Cognet, Robert Lemos, Tonya K. Leeuw, Laura Gumbiner-Russo, R. Bruce Weisman, Garth Powis	2009	81
7	The selective hypoxia inducible factor-1 inhibitor PX-478 providesin vivoradiosensitization through tumor stromal effects Molecular Cancer Therapeutics ·David A. Schwartz, Garth Powis, Arun Thitai-Kumar, Yi He, James A. Bankson, Ryan Williams, Robert Lemos, Junghwan Oh, Andrei Volgin, Suren Soghomonyan, Ryuichi Nishii, Mian M. Alauddin, Uday Mukhopadhay, Zhenghong Peng, William G. Bornmann, Juri G. Gelovani	2009	75
8	Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target Cancer Research ·Geoffrey Grandjean, Petrus R. de Jong, Brian P. James, Mei Yee Koh, Robert Lemos, John Kingston, Alexander E. Aleshin, Laurie A. Bankston, Claudia P. Miller, Eun Jeong Cho, Ramakrishna Edupuganti, Ashwini K. Devkota, Gabriel Stancu, Robert Liddington, Kevin N. Dalby, Garth Powis	2016	68
9	Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor Molecular Cancer Therapeutics ·Emmanuelle J. Meuillet, Zuohe Song, Robert Lemos, Nathan T. Ihle, John Kingston, Ryan Watkins, Sylvestor A. Moses, Shuxing Zhang, Lei Du‐Cuny, Roy S. Herbst, Jörg J. Jacoby, Li Zhou, Ali M. Ahad, Eugene A. Mash, D. Lynn Kirkpatrick, Garth Powis	2010	66
10	In vitro and In vivo Activity of Novel Small-Molecule Inhibitors Targeting the Pleckstrin Homology Domain of Protein Kinase B/AKT Cancer Research ·Sylvestor A. Moses, M. Ahad Ali, Zuohe Song, Lei Du‐Cuny, Li Zhou, Robert Lemos, Nathan T. Ihle, A. Geoffrey Skillman, Shuxing Zhang, Eugene A. Mash, Garth Powis, Emmanuelle J. Meuillet	2009	48
11	Hypoxia-Induced SUMOylation of E3 Ligase HAF Determines Specific Activation of HIF2 in Clear-Cell Renal Cell Carcinoma Cancer Research ·Mei Yee Koh, Vuvi Nguyen, Robert Lemos, Bryant G. Darnay, Galina M. Kiriakova, Mena Abdelmelek, Thai H. Ho, José A. Karam, Federico A. Monzon, Eric Jonasch, Garth Powis	2014	35
12	A new HIF‐1α/RANTES‐driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice Hepatology ·Mei Yee Koh, Mihai Gagea, Timothy Sargis, Robert Lemos, Geoffrey Grandjean, Adriana Charbono, Vasileios Bekiaris, John R. Šedý, Galina M. Kiriakova, Xiuping Liu, Lewis R. Roberts, Carl F. Ware, Garth Powis	2016	33
13	Absence of HIF1A Leads to Glycogen Accumulation and an Inflammatory Response That Enables Pancreatic Tumor Growth Cancer Research ·Marco Maruggi, Fabiana Izidro Layng, Robert Lemos, Guillermina Garcia, Brian P. James, Monica Sevilla, Ferran Soldevilla, Bas Baaten, Petrus R. de Jong, Mei Yee Koh, Garth Powis	2019	24
14	Peroxisome proliferator-activated receptor γ agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activity Molecular Cancer Therapeutics ·Nathan T. Ihle, Robert Lemos, David A. Schwartz, Junghwan Oh, Robert J. Halter, Peter Wipf, Lynn Kirkpatrick, Garth Powis	2009	24
15	An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors Cancer Research ·Martín Indarte, Roisin Puentes, Marco Maruggi, Nathan T. Ihle, Geoffrey Grandjean, Michael J. Scott, Zamal Ahmed, Emmanuelle J. Meuillet, Shuxing Zhang, Robert Lemos, Lei Du‐Cuny, Fabiana Izidro Layng, Ricardo G. Correa, Laurie A. Bankston, Robert Liddington, Lynn Kirkpatrick, Garth Powis	2019	23
16	Abstract 1401: Evaluation of vandetanib (ZD6474) and radiation therapy in an orthotopic xenograft model of anaplastic thyroid carcinoma Cancer Research ·Yunyun Chen, Maria K. Gule, Robert Lemos, Jeffrey N. Myers, David A. Schwartz, James A. Bankson, Stephen Y. Lai	2010	1
17	Abstract 3015: Selective inhibition of mutant KRAS cell and tumor growth by PHT-7.3, an inhibitor of the KRas signaling nanocluster protein Cnk1 Cancer Research ·Roisin Delaney, Marco Maruggi, Martín Indarte, Robert Lemos, Geoff Grandjean, Lynn Kirkpatrick, Garth Powis	2017	1
18	Abstract 4481: Topical application of the dual PDPK1/AKT inhibitor PHT-427 inhibits signaling and growth of human breast cancer cutaneous metastases in mice Cancer Research ·D. Lynn Kirkpatrick, J. L. Johnson, Robert Lemos, Mena Abdelemelek, Nathan T. Ihle, Garth Powis	2011	1
19	Abstract 5534: Metformin increases AMPKα activity by inhibition of AMPKα and cell cycle proliferation in Asian gastric cancer. Cancer Research ·Hae Rim Jung, Hae Ryung Chang, Hye-Hyun Seo, Robert Lemos, Hee Seo Park, Han Liang, Garth Powis, Yon Hui Kim	2013	1
20	Abstract 2916: Targeting lysophospholipid metabolism inhibits pancreatic cancer cell proliferation under nutrient-limiting conditions Cancer Research ·Petrus R. de Jong, Marco Maruggi, Alejandro D. Campos, Morgan A. Brand, Robert Lemos, David A. Scott, Sally A. Litherland, J. Pablo Arnoletti, Brian P. James, Garth Powis	2018	0

About Robert Lemos

Robert Lemos is a scholar working on Cancer Research, Oncology, Molecular Biology, Neurology and Biotechnology, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Metabolism, Diabetes, and Cancer (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Cancer-related Molecular Pathways (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Mechanisms and Therapy (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (531 citations), Oncology (438 citations), Molecular Biology (878 citations), Genetics (99 citations) and Pathology and Forensic Medicine (157 citations). Robert Lemos has collaborated with scholars based in United States, South Korea and Australia. Frequent co-authors include Garth Powis, Mei Yee Koh, Xiuping Liu, Gordon B. Mills, Nathan T. Ihle, D. Lynn Kirkpatrick, Peter Wipf, Clint Mitchell, Paul Dent and Adly Yacoub. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, Nano Research and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact